Valuation: Embecta Corp.

Market Cap 307M 263M 246M 226M 424M 29.35B 431M 2.9B 1.14B 14.72B 1.15B 1.13B 48.67B P/E 2026 *
4.58x
P/E 2027 * 3.93x
Enterprise Value 307M 263M 246M 226M 424M 29.35B 431M 2.9B 1.14B 14.72B 1.15B 1.13B 48.67B EV / Sales 2026 *
0.3x
EV / Sales 2027 * 0.28x
Free-Float
97.98%
Yield 2026 *
4.65%
Yield 2027 * 0.75%
1 day+6.27%
1 week+14.11%
Current month+48.90%
1 month+66.77%
3 months+86.90%
6 months-48.53%
Current year-54.38%
1 week 4.98
Extreme 4.975
5.43
1 month 3.19
Extreme 3.1935
5.43
Current year 2.77
Extreme 2.77
13.44
1 year 2.77
Extreme 2.77
15.55
3 years 2.77
Extreme 2.77
21.48
5 years 0
Extreme 0
49
10 years 0
Extreme 0
49
Manager TitleAgeSince
Chief Executive Officer 58 2022-03-21
Director of Finance/CFO 53 2022-03-21
Investor Relations Contact - 2022-05-31
Director TitleAgeSince
Chairman 58 2026-02-10
Director/Board Member 60 2022-03-19
Director/Board Member 58 2022-03-31
Date Insider Type Main position Quantity % Market Cap.
8/12/26 Buy

General Counsel

20,000 0.0337%
8/12/26 Buy

Chief Financial Officer

20,000 0.0337%
8/12/26 Buy

Chief Executive Officer

30,000 0.0506%
Change 5-day change 1-year change 3-year change Capi.($)
+6.27%+14.11%-60.26%-70.22% 289M
+1.55%+3.17%-12.82%+10.34% 195B
+2.22%+3.71%+4.71%+15.47% 118B
+0.31%+0.93%+7.60%+75.78% 60.33B
+0.06%-4.25%+31.56%+61.72% 55.1B
+3.78%+2.19%-5.27%-31.46% 49.24B
+0.31%-1.01%+11.10%-15.25% 33.81B
-0.62%-4.48% - - 29.94B
+1.79%+0.14%+42.84%-9.02% 24.39B
+4.69%-1.24%-6.38%+25.66% 23.82B
Average +2.04%+1.90%+1.45%+7.00% 58.98B
Weighted average by Cap. +1.56%+1.81%+2.22%+18.07%

Financials

2026 *2027 *
Net sales 1.02B 879M 821M 753M 1.42B 97.92B 1.44B 9.68B 3.79B 49.11B 3.85B 3.76B 162B 1.08B 928M 867M 795M 1.49B 103B 1.52B 10.22B 4B 51.86B 4.06B 3.97B 171B
Net income 69.3M 59.45M 55.51M 50.93M 95.77M 6.62B 97.35M 655M 256M 3.32B 260M 255M 10.98B 76.83M 65.91M 61.54M 56.46M 106M 7.34B 108M 726M 284M 3.68B 288M 282M 12.18B
Net Debt - -
Logo Embecta Corp.
Embecta Corp. is a global medical device company. It provides solutions to improve the health and well-being of people living with diabetes. Its portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through channels, including retail, hospitals and pharmacies. It is also a manufacturer of medical devices and drug delivery technologies.
Employees
1,850
Date Price Change Volume
26-08-19 US$5.420 +6.27% 1,263,132
26-08-18 US$5.100 -0.58% 1,109,457
26-08-17 US$5.130 +0.59% 1,570,681
26-08-14 US$5.100 -0.20% 1,540,033
26-08-13 US$5.110 +7.58% 2,618,693
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
5.420USD
Average target price
4.000USD
Spread / Average Target
-26.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMBC Stock